首页> 外文期刊>Annals of tropical medicine and parasitology >Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum.
【24h】

Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum.

机译:环丙沙星对氯喹对恶性疟原虫临床分离株的体外活性的累加作用。

获取原文
获取原文并翻译 | 示例
       

摘要

As chloroquine and ciprofloxacin each possess substantial inhibitory activity against the schizonts of Plasmodium falciparum, it seems possible that a combination of the two drugs may be clinically useful. The effects on the erythrocytic stages of P. falciparum of combined treatment with chloroquine and ciprofloxacin were therefore evaluated in vitro, using the World Health Organization's standardized micro test. When used alone, the median inhibitory concentration (IC(50)) of chloroquine against the schizonts in the assay mixtures was found to be 7.75 microg/ml, whereas the corresponding value for ciprofloxacin was markedly lower, at 3.35 microg/ml. When they were used together, however, there was marked and statistically significant mutual enhancement of schizont inhibition by the two drugs, indicating that a chloroquine-ciprofloxacin combination may be useful clinically, in the treatment and management of P. falciparum malaria.
机译:由于氯喹和环丙沙星各自对恶性疟原虫的裂殖体具有实质性的抑制活性,因此两种药物的组合可能在临床上可能有用。因此,使用世界卫生组织的标准化微量试验,在体外评估了联合用氯喹和环丙沙星治疗的恶性疟原虫红细胞阶段的作用。当单独使用时,发现氯喹对分析混合物中的裂殖体的中位抑制浓度(IC(50))为7.75微克/毫升,而环丙沙星的相应值则明显较低,为3.35微克/毫升。然而,当将它们一起使用时,两种药物对裂殖体的抑制作用显着且统计学上显着地相互增强,表明氯喹-环丙沙星组合可在临床上用于恶性疟原虫的治疗和管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号